Smith & Nephew SNATS (SNN)
(Real Time Quote from BATS)
$24.58 USD
+0.13 (0.53%)
Updated Apr 29, 2024 03:57 PM ET
After-Market: $24.61 +0.03 (0.12%) 4:12 PM ET
4-Sell of 5 4
A Value A Growth C Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SNN 24.58 +0.13(0.53%)
Will SNN be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for SNN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNN
Smith+Nephew (SNN) Expands in Australia With New Alliance
Fresenius Medical (FMS) to Unveil Training on Augmented Reality
SNN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Investors Undervaluing Smith & Nephew SNATS (SNN) Right Now?
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Is Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?
Other News for SNN
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 21 days
UK earnings, trading statements calendar - next 21 days
UK earnings, trading statements calendar - next 7 days
Global company events calendar